You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
|
|---|---|
| Published in |
Cancer Discovery, May 2020
|
| DOI | 10.1158/2159-8290.cd-19-1014 |
| Pubmed ID | |
| Authors |
Junji Tsurutani, Hiroji Iwata, Ian Krop, Pasi A Jänne, Toshihiko Doi, Shunji Takahashi, Haeseong Park, Charles Redfern, Kenji Tamura, Trisha M Wise-Draper, Kaku Saito, Masahiro Sugihara, Jasmeet Singh, Takahiro Jikoh, Gilles Gallant, Bob T Li |
X Demographics
The data shown below were collected from the profiles of 99 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 29 | 29% |
| Italy | 7 | 7% |
| France | 5 | 5% |
| United Kingdom | 4 | 4% |
| Nigeria | 2 | 2% |
| Switzerland | 2 | 2% |
| Mexico | 2 | 2% |
| Canada | 2 | 2% |
| Germany | 1 | 1% |
| Other | 9 | 9% |
| Unknown | 36 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 52 | 53% |
| Scientists | 26 | 26% |
| Practitioners (doctors, other healthcare professionals) | 18 | 18% |
| Science communicators (journalists, bloggers, editors) | 3 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 184 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 35 | 19% |
| Other | 18 | 10% |
| Student > Postgraduate | 16 | 9% |
| Student > Ph. D. Student | 15 | 8% |
| Student > Bachelor | 12 | 7% |
| Other | 18 | 10% |
| Unknown | 70 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 28% |
| Biochemistry, Genetics and Molecular Biology | 14 | 8% |
| Agricultural and Biological Sciences | 10 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Nursing and Health Professions | 4 | 2% |
| Other | 16 | 9% |
| Unknown | 83 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 205. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2023.
All research outputs
#195,105
of 25,734,859 outputs
Outputs from Cancer Discovery
#75
of 4,153 outputs
Outputs of similar age
#6,714
of 411,358 outputs
Outputs of similar age from Cancer Discovery
#4
of 89 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 411,358 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.